BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 24238925)

  • 1. Structural imaging in late-life depression: association with mood and cognitive responses to antidepressant treatment.
    Marano CM; Workman CI; Lyman CH; Munro CA; Kraut MA; Smith GS
    Am J Geriatr Psychiatry; 2015 Jan; 23(1):4-12. PubMed ID: 24238925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct functional networks associated with improvement of affective symptoms and cognitive function during citalopram treatment in geriatric depression.
    Diaconescu AO; Kramer E; Hermann C; Ma Y; Dhawan V; Chaly T; Eidelberg D; McIntosh AR; Smith GS
    Hum Brain Mapp; 2011 Oct; 32(10):1677-91. PubMed ID: 20886575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between change in brain gray matter volume, cognition, and depression severity: Pre- and post- antidepressant pharmacotherapy for late-life depression.
    Droppa K; Karim HT; Tudorascu DL; Karp JF; Reynolds CF; Aizenstein HJ; Butters MA
    J Psychiatr Res; 2017 Dec; 95():129-134. PubMed ID: 28843842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular imaging of the serotonin transporter availability and occupancy by antidepressant treatment in late-life depression.
    Smith GS; Kuwabara H; Gould NF; Nassery N; Savonenko A; Joo JH; Bigos KL; Kraut M; Brasic J; Holt DP; Hall AW; Mathews WB; Dannals RF; Nandi A; Workman CI
    Neuropharmacology; 2021 Aug; 194():108447. PubMed ID: 33450276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular imaging of beta-amyloid deposition in late-life depression.
    Smith GS; Kuwabara H; Nandi A; Gould NF; Nassery N; Savonenko A; Joo JH; Kraut M; Brasic J; Holt DP; Hall AW; Mathews WB; Dannals RF; Avramopoulos D; Workman CI
    Neurobiol Aging; 2021 May; 101():85-93. PubMed ID: 33592548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment course with antidepressant therapy in late-life depression.
    Sheline YI; Disabato BM; Hranilovich J; Morris C; D'Angelo G; Pieper C; Toffanin T; Taylor WD; MacFall JR; Wilkins C; Barch DM; Welsh-Bohmer KA; Steffens DC; Krishnan RR; Doraiswamy PM
    Am J Psychiatry; 2012 Nov; 169(11):1185-93. PubMed ID: 23534057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of regional gray matter volume abnormalities in Alzheimer׳s disease and late life depression with hippocampal atrophy using VSRAD analysis: a voxel-based morphometry study.
    Shimoda K; Kimura M; Yokota M; Okubo Y
    Psychiatry Res; 2015 Apr; 232(1):71-5. PubMed ID: 25773003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of brain structural variables, neuropsychological factors, and treatment outcome in early-onset versus late-onset late-life depression.
    Disabato BM; Morris C; Hranilovich J; D'Angelo GM; Zhou G; Wu N; Doraiswamy PM; Sheline YI
    Am J Geriatr Psychiatry; 2014 Oct; 22(10):1039-46. PubMed ID: 23768683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fractional amplitude of low-frequency fluctuations and gray matter volume alterations in patients with bipolar depression.
    Sun N; Li Y; Zhang A; Yang C; Liu P; Liu Z; Wang Y; Jin R; Zhang K
    Neurosci Lett; 2020 Jun; 730():135030. PubMed ID: 32389612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trajectories in Cerebral Blood Flow Following Antidepressant Treatment in Late-Life Depression: Support for the Vascular Depression Hypothesis.
    Wei W; Karim HT; Lin C; Mizuno A; Andreescu C; Karp JF; Reynolds CF; Aizenstein HJ
    J Clin Psychiatry; 2018 Oct; 79(6):. PubMed ID: 30358242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medial prefrontal cortex activity during memory encoding of pictures and its relation to symptomatic improvement after citalopram treatment in patients with major depression.
    Roy M; Harvey PO; Berlim MT; Mamdani F; Beaulieu MM; Turecki G; Lepage M
    J Psychiatry Neurosci; 2010 May; 35(3):152-62. PubMed ID: 20420766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of HMPAO SPECT in predicting treatment response to citalopram in patients with major depression.
    Brockmann H; Zobel A; Joe A; Biermann K; Scheef L; Schuhmacher A; von Widdern O; Metten M; Biersack HJ; Maier W; Boecker H
    Psychiatry Res; 2009 Aug; 173(2):107-12. PubMed ID: 19540732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of bupropion extended release on negative emotion processing in major depressive disorder: a pilot functional magnetic resonance imaging study.
    Robertson B; Wang L; Diaz MT; Aiello M; Gersing K; Beyer J; Mukundan S; McCarthy G; Doraiswamy PM
    J Clin Psychiatry; 2007 Feb; 68(2):261-7. PubMed ID: 17335325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal studies of cerebral glucose metabolism in late-life depression and normal aging.
    Marano CM; Workman CI; Kramer E; Hermann CR; Ma Y; Dhawan V; Chaly T; Eidelberg D; Smith GS
    Int J Geriatr Psychiatry; 2013 Apr; 28(4):417-23. PubMed ID: 22740289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Escitalopram enhances synchrony of brain responses during emotional narratives in patients with major depressive disorder.
    Komulainen E; Glerean E; Heikkilä R; Nummenmaa L; Raij TT; Isometsä E; Ekelund J
    Neuroimage; 2021 Aug; 237():118110. PubMed ID: 33933596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward a neuroimaging treatment selection biomarker for major depressive disorder.
    McGrath CL; Kelley ME; Holtzheimer PE; Dunlop BW; Craighead WE; Franco AR; Craddock RC; Mayberg HS
    JAMA Psychiatry; 2013 Aug; 70(8):821-9. PubMed ID: 23760393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant effects of tDCS are associated with prefrontal gray matter volumes at baseline: Evidence from the ELECT-TDCS trial.
    Bulubas L; Padberg F; Bueno PV; Duran F; Busatto G; Amaro E; Benseñor IM; Lotufo PA; Goerigk S; Gattaz W; Keeser D; Brunoni AR
    Brain Stimul; 2019; 12(5):1197-1204. PubMed ID: 31105027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of lingual gyrus volume on antidepressant response and neurocognitive functions in Major Depressive Disorder: a voxel-based morphometry study.
    Jung J; Kang J; Won E; Nam K; Lee MS; Tae WS; Ham BJ
    J Affect Disord; 2014 Dec; 169():179-87. PubMed ID: 25200096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The common traits of the ACC and PFC in anxiety disorders in the DSM-5: meta-analysis of voxel-based morphometry studies.
    Shang J; Fu Y; Ren Z; Zhang T; Du M; Gong Q; Lui S; Zhang W
    PLoS One; 2014; 9(3):e93432. PubMed ID: 24676455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between insomnia and cognitive performance, gray matter volume, and white matter microstructure in cognitively unimpaired adults.
    Grau-Rivera O; Operto G; Falcón C; Sánchez-Benavides G; Cacciaglia R; Brugulat-Serrat A; Gramunt N; Salvadó G; Suárez-Calvet M; Minguillon C; Iranzo Á; Gispert JD; Molinuevo JL;
    Alzheimers Res Ther; 2020 Jan; 12(1):4. PubMed ID: 31907066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.